Perth, Western Australia - July 2, 2024: - Biotome Pty Ltd , a Western Australian biotechnology company, has been awarded an Innovation Booster Grant from the Western Australian Government's New Industries Fund . This grant will support the development and international patenting of Biotome's innovative preeclampsia risk test. The test, which uses novel peptide targets to detect specific antibodies in the blood, aims to provide early risk assessment for preeclampsia, a condi

Thursday, September 14th, 2022 - Perth, Australia: Biotome is part of an international consortium that has been awarded a grant from the Leducq Foundation for the Acute Rheumatic Fever Diagnosis Collaborative Network (ARC Network). The goal of this project is to discover biomarkers that accurately identify patients with acute rheumatic fever. Acute rheumatic fever [ARF] is a serious complication following a strep throat infection caused by Group A Streptococcus bacteria. It

Tuesday, July 5th, 2022 - Perth, Australia: Biotome has been awarded $497,000 in funding from the Western Australian Future Health Research & Innovation Fund , to develop their precision diagnostic for stomach cancer risk. This test will be the world’s first diagnostic for stomach cancer risk with high enough accuracy and a low enough cost to be used for public health screening. It has the potential to save thousands of lives in Australia, and millions around the world. Biot

Perth, Australia April 5, 2021 – BrainChip Holdings Ltd (ASX: BRN), a leading provider of ultra-low power high performance artificial intelligence technology, today announced that the Brainchip Research Institute in Perth has entered into a research collaboration with precision immunology company Biotome Pty Ltd. Biotome is developing highly accurate antibody tests for infections. The Akida neuromorphic processor chip will be used to interpret sensor responses and to find ou